(PharmaNewsWire.Com, March 10, 2021 ) According to the new market research report Life Science Analytics Market is expected to reach 42.0 billion by 2025 from USD 22.1 billion in 2020, at a CAGR of 13.7% during the forecast period of 2020 to 2025.
Growth in this market is mainly driven by technological advancements, big data in the life science industry, growing adoption of analytics solutions in clinical trials, increasing adoption of analytics for sales & marketing applications, need for improved data standardization, increasing prevalence of chronic diseases, growing pressure to curb healthcare spending, and the need for improved patient outcomes.
The life science analytics market is a highly diversified and competitive market, with a large number of players, including mid-tier companies and startup firms, competing for market shares. SAS Institute, Inc. (US), IBM Corporation (US), Oracle Corporation (US), Quintiles, Inc. (US), Accenture (Ireland), Cognizant (US), Wipro (India), MaxisIT, Inc. (US), TAKE Solutions (India), and SCIO Health Analytics (US) are some of the key players in this market. These players have adopted various growth strategies, such as product launches & upgrades; expansions; mergers & acquisitions; and partnerships, agreements, and collaborations, to further expand their presence in the global market.
Agreements, partnerships, and collaborations were the key growth strategies adopted by players from 2017 to 2020. Some of the leading players who adopted these strategies are SAS Institute (US), Wipro Limited (India), Accenture (Ireland), IBM Corporation (US), and IQVIA (US).
SAS Institute, Inc. (US)
SAS Institute is one of the key players in the life science analytics market. To maintain its leading position in the market, the company adopts organic as well as inorganic growth strategies such as expansions, partnerships, and collaborations. For example, in March 2019, SAS collaborated with NVIDIA to design artificial intelligence (AI) for industries such as healthcare, life sciences, manufacturing, and financial services. In May 2019, SAS launched its SAS Cloud offering in an Amazon Web Services’ Data Center in Singapore. Such developments enable the company to enhance its presence in this market. The company also focuses on research & development activities to develop innovative solutions for stakeholders and maintain its position in the life science analytics market.
Oracle Corporation (US)
Oracle, with its broad customer base of over 430,000 customers and geographic presence in over 175 countries, is a key player in a range of IT software, hardware, and service-related markets, including the life science analytics market. The company focuses on continuously updating its products and meeting customer expectations. To provide tailored solutions, Oracle is continuously investing in expanding its cloud-based solutions segment. For instance, in April 2016, the company launched a cloud version of the Oracle Health Sciences Safety Suite 8.0 for pharmaceutical companies.
IBM Corporation (US)
IBM Corporation is one of the leading players in the life science analytics market. The company’s strong position in the market can be attributed to its brand recognition and extensive product offerings. The company focuses on inorganic as well as organic growth strategies such as acquisitions, collaborations, expansions, and product launches in order to expand its existing product portfolio and strengthen its market position. For instance, in June 2017, IBM and Cornell University announced a new collaboration using next-generation sequencing combined with big data analytics. In February 2017, the company launched the Watson Platform for Health Cloud and a specialized Watson Health Consulting Services unit. Such developments are expected to help the company to maintain its strong presence in the market.
In 2019, North America accounted for the largest market share, followed by Europe. The large share of this market can primarily be attributed to the strong economies in the US and Canada, which have allowed for significant investments in technology in this region. Growth in the North American market is supported by the growing adoption of IT in the life science industry, rising pressure to reduce healthcare costs, stringent regulations for the pharma-biotech and medical device industries, and the greater product and service availability in this region.
Contact: Mr. Aashish Mehra MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA: +1-888-600-6441 sales@marketsandmarkets.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
